Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma. Metabolic Syndrome and Related Disorders coverage includes: -Insulin resistance -Central obesity -Glucose intolerance -Dyslipidemia with elevated triglycerides -Low HDL-cholesterol -Microalbuminuria -Predominance of small dense LDL-cholesterol particles -Hypertension -Endothelial dysfunction -Oxidative stress -Inflammation -Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout
YEAR | Impact Factor |
---|---|
2023-24 | 1.3 |
2022 | 2.1 |
2021 | 2.363 |
Metabolic Syndrome and Related Disorders, 1540-4196, 2004-ongoing, Medicine.